J P Morgan Chase & Co Reiterates “Buy” Rating for Roche Holding Ltd. (ROG)

J P Morgan Chase & Co restated their buy rating on shares of Roche Holding Ltd. (VTX:ROG) in a report released on Monday, October 16th. J P Morgan Chase & Co currently has a target price on the healthcare company’s stock.

A number of other research analysts have also recently issued reports on the company. Goldman Sachs Group, Inc. (The) set a CHF 325 price objective on Roche Holding and gave the stock a buy rating in a report on Monday, September 11th. Credit Suisse Group set a CHF 300 price objective on Roche Holding and gave the stock a buy rating in a report on Monday, September 11th. Citigroup Inc reissued a buy rating on shares of Roche Holding in a report on Wednesday, July 5th. Societe Generale set a CHF 275 price objective on Roche Holding and gave the stock a neutral rating in a report on Thursday, June 29th. Finally, Baader Bank set a CHF 231 price objective on Roche Holding and gave the stock a neutral rating in a report on Tuesday, September 12th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and five have issued a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of CHF 263.

Shares of Roche Holding (VTX ROG) opened at 229.80 on Monday. The stock has a 50 day moving average of CHK 244.08 and a 200-day moving average of CHK 250.24. Roche Holding has a one year low of CHK 218.30 and a one year high of CHK 273.00. The firm has a market capitalization of CHK 196.08 billion and a price-to-earnings ratio of 20.40.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/10/27/j-p-morgan-chase-co-reiterates-buy-rating-for-roche-holding-ltd-rog.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply